Venn Life Sciences (LON:VENN) Stock Passes Above 50-Day Moving Average of $6.85

Venn Life Sciences Holdings PLC (LON:VENN) shares crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 6.85 ($0.09) and traded as high as GBX 7 ($0.09). Venn Life Sciences shares last traded at GBX 6.85 ($0.09), with a volume of 1,027,544 shares changing hands.

Venn Life Sciences Stock Performance

The company has a debt-to-equity ratio of 35.83, a quick ratio of 1.48 and a current ratio of 2.30. The firm has a market capitalization of £4.89 million and a PE ratio of -2.14. The business’s fifty day simple moving average is GBX 6.85 and its 200-day simple moving average is GBX 6.85.

Venn Life Sciences Company Profile

Venn Life Sciences Holdings Plc, a clinical research organization, provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device companies in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. The company offers drug development planning and strategy services, including clinical feasibility assessment, project management, and in-licensing and technical due diligence; and early drug development services, such as drug candidate selection, CMC, non-clinical/pre-clinical development, clinical pharmacology, pharmacokinetics, and pharmacometrics and PK-PD modelling.